Management of myasthenia gravis.
D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use; D010951:Plasma Exchange; D013934:Thymectomy
D007166:Immunosuppressive Agents; D009388:Neostigmine